[Effect of gastrin and enprostil, a PGE2 analog, on colonic cancerous cell growth].
The effects of gastrin (G-17), proglumide (a gastrin receptor antagonist), and enprostil (a synthetic analog of prostaglandin E2) used alone or in association were studied in colonic cancer Prob and Regb cell growth. The Prob (progressive in BD IX rats) and Regb (regressive) cell lines were cloned from a single chemically-induced rat colonic cancer. After a serum-free period corresponding to one doubling cell time, cells were incubated with 100 to 1,200 pM G-17, 40 or 80 mM proglumide, and 2.5 to 5 micrograms/ml enprostil for 8 h. Cell growth was measured 48 h later by colorimetric MTT assay. Two and four hundred pM G-17 gave a growth stimulation of 17.4 percent and 31 percent for Prob cells respectively or 35.5 percent and 49 percent for Regb cells. Growth stimulation was found to be statistically different (P less than 0.01) for Prob and Regb cells. Proglumide partially inhibited this growth stimulation whereas enprostil inhibited in totally. These results suggest that growth of some colonic cancer cell lines may be G-17 dependent. However the intensity of cell-growth stimulation depends on the level of cell malignancy or differentiation in a single tumor.
Laboratoire de Recherches, Hôpital Laennec, Nantes.
S
S
Yactayo
T
T
Patrice
M T
MT
Foultier
A
A
Berrada
X N
XN
Xu
D000230:Adenocarcinoma / Q000139:chemically induced / Q000235:genetics / Q000473:pathology; D000818:Animals; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D004127:Dimethylhydrazines / Q000009:adverse effects; D004338:Drug Combinations; D016620:Enprostil / Q000494:pharmacology*; D005755:Gastrins / Q000494:pharmacology*; D011377:Proglumide / Q000494:pharmacology*; D051381:Rats; D013268:Stimulation, Chemical; D014407:Tumor Cells, Cultured / Q000187:drug effects* / Q000473:pathology
D004127:Dimethylhydrazines; D004338:Drug Combinations; D005755:Gastrins; C013550:gastrin 17; D011377:Proglumide; D016620:Enprostil
Influence de la gastrine et de l'enprostil, analogue de la PGE2, sur la croissance de cellules cancéreuses coliques.